Cargando…
miR-378a-5p improved the prognosis and suppressed the progression of hepatocellular carcinoma by targeting the VEGF pathway
BACKGROUND: The malignant tumor hepatocellular carcinoma (HCC) has a poor prognosis and ineffective therapeutic options. miR-378a-5p is a micro-ribonucleic acid (miRNA) that is overexpressed in many cancers. However, its role in the progression of human HCC is unclear. METHODS: Quantitative real-tim...
Autores principales: | Zou, Haibo, Yang, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798882/ https://www.ncbi.nlm.nih.gov/pubmed/35117503 http://dx.doi.org/10.21037/tcr.2020.01.46 |
Ejemplares similares
-
Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation in hepatocellular carcinoma
por: Zhou, Jin, et al.
Publicado: (2018) -
A Genetic Variant in Primary miR-378 Is Associated with Risk and Prognosis of Hepatocellular Carcinoma in a Chinese Population
por: An, Jiaze, et al.
Publicado: (2014) -
MiR‐378a‐3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation
por: Qian, Fuliang, et al.
Publicado: (2021) -
Identification of serum miR-378 and miR-575 as diagnostic indicators and predicting surgical prognosis in human epilepsy
por: Li, Xiuxiu, et al.
Publicado: (2022) -
Depicting the Implication of miR-378a in Cancers
por: Qin, Yuelan, et al.
Publicado: (2022)